High serum LDH and liver metastases are the dominant predictors of primary cancer resistance to anti-PD(L)1 immunotherapy
Laurent Dercle, Samy Ammari, Elvire Roblin, Amélie Bigorgne, Stéphane Champiat, Lokmane Taihi, Athèna Plaian, Sophie Hans, Sara Lakiss, Lambros Tsélikas, Mathieu Rouanne, Éric Deutsch, Lawrence H. Schwartz, Mithat Gönen, Jessica Flynn, Christophe Massard, Jean‐Charles Soria, Caroline Robert, Aurélien Marabelle
Topics & Concepts
MedicineInternal medicineImmunotherapyMelanomaClinical trialCancerMultivariate analysisOncologyGastroenterologyPopulationEnvironmental healthCancer researchCancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and ManagementImmunotherapy and Immune Responses